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ABSTRACT: Polyphenols have been extensively exploited in the biomedical field because of their
wide range of bioactive properties and historical use as traditional medicines. They typically present
antioxidant, antimicrobial, antiamyloidogenic, and/or antitumor activities. In particular, cork water
extracts and their components, have been previously reported to present antioxidant and
antiamyloidogenic properties. On the basis of this knowledge, we tested cork water extract (CWE),
cork water enriched extract (CWE-E), vescalagin/castalagin (two of the main polyphenols present in
CWE and CWE-E) for their antibacterial activity against four bacterial strains, namely, methicillin-
resistant Staphylococcus epidermidis (MRSE), Staphylococcus aureus (SA), methicillin-resistant
Staphylococcus aureus (MRSA), and Pseudomonas aeruginosa (PA). Vescalagin and castalagin
presented bactericidal activity against all the tested bacterial strains, in particular toward the
methicillin-resistant ones, i.e., MRSA and MRSE, as well as the ability to inhibit the formation of
biofilms and to disrupt preformed ones. Moreover, vescalagin/castalagin seem to modulate the
normal assembly of the peptidoglycans at the bacteria surface, promoting the disruption of their cell
wall, leading to bacterial cell death. We also demonstrate that vescalagin/castalagin can be loaded
into alginate hydrogels to generate antibacterial biomaterials that are not toxic to eukaryotic cells.
KEYWORDS: cork, vescalagin, castalagin, methicillin-resistant Staphylococcus epidermidis, Staphylococcus aureus,
methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa
■ INTRODUCTION
Pathogenic bacteria are a serious health concern in modern
society, as they present increasing resistance to the most
common antibiotics.1 They are associated with chronic
infections and severe inflammation due to their ability to
create a physical and chemical barrier (through the
extracellular matrix) to external factors, enhancing their
resistance to therapeutic strategies.2 They grow under both
static and continuous flow conditions in a dense layer of cells
within an elaborate matrix that harbors various types of
biopolymers including phenol-soluble modulins (PSMs),
alginate, exopolysaccharides, extracellular DNA, and different
proteins able to generate amyloid-like fibers (i.e., curli or
fimbriae), which in turn are used by bacteria to aggregate, form
microcolonies, and generate biofilms.3−5
Biofilms are extremely common, being present in water
pipes (inner surfaces), on dental plaque, in lung infections, and
general infections related to the use of medical devices.6 They
are described as compact aggregates of bacteria attached to a
surface and surrounded by a mesh of extracellular polymeric
substances (EPS) that are produced over time (composed by
approximately 5−25% of bacterial cells and 75−95% of
glycocalyx matrix).7 The bacterial surface is also composed
by amyloid-like fibers that play a role in adherence, as well as
colanic acid, an exopolysaccharide involved in aggregation.8
Biofilms enhance bacterial survival, as they are protected from
environmental stress such as nutrient deprivation, unphysio-
logical temperatures, and pH changes, making them more
resistant to detachment, oxygen radicals, disinfectants, and
antibiotics. Consequently, bacteria embedded in mature
biofilms can tolerate antimicrobial agents at concentrations
10−1000× higher than the ones needed to kill genetically
equivalent individual bacteria.9 Biofilms are not required for
bacteria survival; it is an adaptation that enhances survival,
metabolism, and propagation of bacteria, especially under
adverse conditions. In contrast, circulating bacteria are able to
colonize new microenvironments, however they present a
lower chance of survival.8 Therefore, strategies that block the
production of adherent proteins (e.g., able to form curli and
amyloid-like fibers) or to inhibit their activity, are extremely
relevant to reduce the formation of biofilms from different
types of pathogenic bacteria that are resistant to antibiotics,
e.g., methicillin-resistant ones.
Importantly, bacteria are divided into Gram-positive and
Gram-negative, a classification that is related to the chemical/
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physical composition of the cell membrane that protect their
cytoplasm from external aggression.10 Although Gram-positive
bacteria have a thick layer of peptidoglycans,11 in the Gram-
negative bacteria this layer is thinner; however, they present an
additional outer membrane that contains a unique type of
component, i.e., lipopolysaccharides, and an inner membrane
composed of proteins and phospholipids.3,12,13
Polyphenols have been studied as alternative antibacterial
agents.14 They are essential components of plants where they
can be found in a series of different roles.15 They are not
involved in the normal growth and maturation of plants (as
they are secondary metabolites), however, they have a critical
role in the plants’ defense mechanisms against viruses, bacteria,
or fungi.16 The antioxidant and antimicrobial activities of these
molecules are related to the number of phenyl rings and the
number of conjugated hydroxyl groups (e.g., galloyl units).17
Polyphenols (e.g., epigallocatechin gallate (EGCG), resvera-
trol, etc.) or tannins have been tested for a range of different
pathologies (i.e., inflammation, cardiovascular diseases, cancer,
and neurodegenerative disorders, among others), or as
molecules that are able to enhance the human immune
response mechanisms.18−20
Cork is a relevant natural source of polyphenols. In fact, we
previously demonstrated that it is possible to extract a series of
phenolic compounds using hot water, i.e., cork water extract
(CWE), with important antioxidant activity.21 On the basis of
these results, we also showed that it is possible to use CWE or
vescalagin/castalagin (isolated from CWE) to protect DNA
from UV-mediated damage and subsequent cell death,22 or as
antiamyloidogenic agents.23
In the context of antibacterial activity, the mechanism of
action of most polyphenols is reported to be related to their
ability to target the bacterial membrane, interacting with the
lipids and its subsequent permeabilization.24 Of note, in a
previous study, we demonstrated that vescalagin/castalagin was
able to interact with the amyloidogenic peptide Aβ42,
inhibiting the generation of cytotoxic supramolecular forms
and modulating its activity. Importantly, amyloids are highly
abundant in the matrices of biofilms of diverse bacterial
species, sharing a common structural feature, i.e., cross-β-
sheets.25 These bacterial amyloid-like fibers mediate adhesion
and promote biofilm formation, as they are a relevant target to
inhibit the formation of biofilms.26
Herein, we used the knowledge from our previous results
and explored the antibacterial capacity of cork-based
polyphenols, namely, the CWE, vescalagin, and castalagin
(Figure 1). We also tested the enrichment of CWE in
vescalagin, through the use of an additional subsequent
extraction with ethanol (CWE-E). We tested these extracts/
polyphenols against four different pathogenic bacteria strains,
methicillin-resistant Staphylococcus epidermidis (MRSE, ATCC
35984), Staphylococcus aureus (SA, ATCC 25923), methicillin-
resistant Staphylococcus aureus (MRSA, ATCC 700698), and
Pseudomonas aeruginosa (PA, ATCC 27853).
■ RESULTS AND DISCUSSION
We started by extracting CWE and CWE-E, as well as isolating
the polyphenols vescalagin/castalagin (characterization is
presented in Figures S1−S5). We then evaluated their
antioxidant activity using the DPPH assay (Figure S6) to
understand if there was a relationship between antioxidant and
antibacterial activities. The second ethanol extraction, yielding
CWE-E from the CWE extract, allowed an enrichment in the
vescalagin content, and this is reflected in the antioxidant
potential of the CWE-E (∼10% higher than the original
CWE). Of note, the purified vescalagin presented ∼30% higher
antioxidant activity than CWE, whereas in the case of
castalagin, an ∼37% increment was observed. These results
could be directly related to antibacterial activity: (i) due to the
anti- and pro-oxidant capacity of the galloyl moieties present in
the molecular structure of the polyphenols (these molecules
can oxidize readily in aqueous solution, acting as pro-oxidants,
i.e., producing reactive oxygen species and a complex mixture
of quinones, which are potentially cytotoxic),27 thus, leading to
the formation of peroxides and their restructuring to form o-
diphenols (increasing the free-radical scavenging capacity);28
(ii) the formation of o-diphenols is linked with the
polyphenols’ ability to complex with proteins (at the surface
of the cell wall);29 (iii) polyphenols are reported to interact
with the polar regions of the lipid bilayer, promoting lipid
peroxidation and therefore inhibiting bacterial growth;16 and
(iv) it has been reported that their antioxidant activity is linked
to the ability of these molecules to promote metal-ion
deficiency based on their chelating ability, leading to the
inhibition of bacterial enzymatic activity due to substrate
deprivation.30
To evaluate if the cork-derived extracts/polyphenols are able
to act as antibacterial agents, we started with disc diffusion
tests (Figures S7 and S8 and Table S1). The results showed
that vescalagin/castalagin presented clear antibacterial activity
toward all the Gram-positive bacteria. We then evaluated their
minimum inhibitory concentration (MIC, Table 1) and
minimum bactericidal concentration (MBC, Table S2)
Figure 1. (A) Chemical structure of the polyphenols vescalagin and
castalagin purified from CWE. (B) Schematic presentation of the
mechanism of action of vescalagin/castalagin: (i) Gram-negative,
antibacterial activity through the diffusion into a region near the
peptidoglycans layer; (ii) Gram-positive,direct binding of vescalagin/
castalagin to the peptidoglycan of the bacterial cell wall and its
subsequent disruption.
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towards the same bacterial strains, i.e., MRSE, SA, and MRSA.
In general, all the tested bacteria are affected by the presence of
the cork extracts/polyphenols. Importantly, vescalagin/casta-
lagin seems to be the components present in the CWE/CWE-
E that present higher antibacterial activity, with MIC values
between 0.125 and 0.250 mg/mL and MBCs between 0.250
and 1.000 mg/mL. Of note, it was observed a higher sensitivity
of the methicillin-resistant strains to vescalagin/castalagin than
the nonresistant strain.
In the case of the Gram-negative bacterium PA, it presented
a higher MIC/MBC (only measured for the purified
compounds, i.e., vescalagin/castalagin, Table 1 and Table
S2). It seems that the outer membrane of the Gram-negative
bacteria renders additional resistance to the tested compounds.
In contrast, our results are consistent with the high efficiency
of vescalagin/castalagin to disrupt the peptidoglycan layer of
the cell wall from the Gram-positive bacteria. In addition,
overall, for both Gram-positive and Gram-negative bacteria, we
observed a direct relation between antioxidant and anti-
bacterial activity, as CWE-E presented lower MBCs than CWE,
which correlates with its significantly higher antioxidant
activity, suggesting that it is contributing to its capacity to
promote bacterial cell death.
We then used the Live/Dead assay (Figures 2 and 3 and
Figure S9) to confirm the MIC/MBC results. In this case, it is
clear that vescalagin and castalagin effectively suppress the
bacteria proliferation at the MIC concentrations (presented in
Table 1), drastically reducing the percentage of live bacteria
cells (Figure 3). Overall, and in accordance with the disc
diffusion, MIC, and MBC results, it is surprising that vescalagin
and castalagin present lower MICs and MBCs against MRSE
and MRSA than against SA. Hence, we hypothesize that the
mechanism of action of vescalagin/castalagin is partially linked
to their capacity to interact with the proteins at the surface of
the bacteria cell wall responsible for the methicillin resistance.
If we compare the MRSA and SA bacterial strains, their main
difference is based on the capacity of MRSA (and not SA) to
produce an additional penicillin-binding protein, PBP2a (as a
result of an extensive use of β-lactam class of antibiotics, these
strains became resistant to an entire class of β-lactam-based
antibiotics). Although PBPs make MRSA and MRSE resistant
to common antibiotics, they are also responsible for the final
step of the synthesis of peptidoglycans (covalently cross-linked
units of N-acetylglucosamine and N-acetylmuramic acid).4
Specifically, the serine nucleophile of the PBP2a active site
changes its supramolecular assembly to diminish the reactivity
against β- lactam.
Also, the loop in the PBP2a protein protects its active site
from the β-lactam antibiotics.31 In addition, some methicillin-
resistant cell-wall-anchored proteins are composed by several
connecting subdomains folded into β-sheet rich regions.32
These supramolecular arrangements can explain the lower
MIC values for vescalagin toward methicillin-resistant bacteria
Table 1. Minimum Inhibitory Concentration (MIC, mg/
mL) of Each Extract/Polyphenol, i.e., CWE, CWE-E,
Vescalagin, and Castalagin, toward the Four Tested Strains
of Bacteria, Methicillin-ResistantStaphylococcus epidermidis
(MRSE), Staphylococcus aureus (SA), Methicillin-
ResistantStaphylococcus aureus (MRSA), and Pseudomonas
aeruginosa (PA)
Extract/polyphenol MIC(mg/mL)
Strain of bacteria CWE CWE-E vescalagin castalagin
MRSE 0.500 0.500 0.125 0.250
SA 2.000 1.000 0.500 0.500
MRSA 2.000 1.000 0.125 0.125
PA NIa NIa 1.000 1.000
aNI: No inhibition at concentrations up to 2.50 mg/mL.
Figure 2. Representative Live/Dead images (in green live cells and in
red dead cells) showing the antibacterial activity of vescalagin and
castalagin (at their MIC concentration) toward methicillin-resistant
Staphylococcus epidermidis (MRSE), Staphylococcus aureus (SA),
methicillin-resistant Staphylococcus aureus (MRSA), and Pseudomonas
aeruginosa (PA); scale bar = 200 μm.
Figure 3. Quantification of live bacteria (as a percentage of the total
live + dead ones found in the control sample). Quantification was
executed using the fluorescence images obtained from the samples
stained with BacLight Viability Kit (at the respective MIC
concentration). Statistical significance: *** p < 0.001, ** p < 0.01,
and * p < 0.05 (vs Ctr, i.e., bacterial culture in the absence of
vescalagin/castalagin); n = 3.
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as being due to its proven higher antiamyloidogenic capacity
when compared with castalagin.23,33
In the case of PA, the efficacy of CWE, CWE-E, and
vescalagin/castalagin is lower. It is important to consider that
PA is the only Gram-negative bacterium that we tested. This
lower activity of the cork-derived extracts/polyphenols is, as
previously suggested, probably due the different organization
of its outer membrane. However, it is also important to
consider that PA is associated with serious illnesses (e.g.,
infections such as ventilator-associated pneumonia) and
presents complex antibiotic resistance mechanisms,34 which
might be also at play in its resistance toward vescalagin/
castalagin.
The formation of biofilms increases the capacity of bacteria
to resist external aggressions. To evaluate if the extracts/
polyphenols were able to act under these circumstances and if
they were able to target proteins that mediate adhesion and
biofilm formation, we used scanning electron microscopy
(SEM, Figure 4) to visualize the bacteria in the presence and
absence of the extracts/polyphenols. Both vescalagin and
castalagin clearly reduced the number of bacteria and altered
their morphology by promoting the disruption of the bacterial
cell wall. In addition, their extracellular matrix also appears
unstructured, confirming the MIC/MBC data. After showing
that vescalagin/castalagin reduce the formation of biofilms, we
tested if they were also able to act once the biofilms are already
formed (Figure 5). In this case, we observed a clear reduction
of the preformed biofilms generated by all the tested strains of
bacteria, using the MICs of vescalagin/castalagin. Importantly,
in the cases of the Gram-positive bacteria, i.e., MRSE, MRSA,
and SA, we were able to observe this reduction even at
concentrations below their MICs.
To evaluate if vescalagin/castalagin could interfere with the
formation of β-sheet rich structures essential for cell survival,
we used the Congo red agar (CRA) assay,35 as it is usually
sensitive to the presence of amyloid-like protein structures.
Congo red is able to bind to these types of supramolecular
structures, namely, the ones generated by polysaccharide
intercellular adhesin, i.e., PIA or PSMs (in Staphylococcus
strains), and exopolysaccharides, such as Pel and Psl in
PA.36−40 In general, the formation of light-colored colonies of
MRSE, MRSA, and SA is associated with the inexistence of
biofilm (and reduced concentration of β-sheet structures),
whereas darker ones are consistent with formation of biofilm
(rich in β-sheet structures).41
In the CRA assay, we used a concentration below the MIC
values (presented in Table 1) because at those concentrations
(and above) it was observed a strong (and dose-dependent)
inhibition of the colony formation, being difficult to extract
relevant conclusions (Figures S11−S14). The CRA assay
(Figure 6) showed that both vescalagin and castalagin caused a
strong inhibition of the formation of biofilm (and cross β-sheet
structures) by the MRSE, SA and MRSA strains. In the case of
PA, its biofilm is stained light red by Congo red (Figure 6D).
Reports have shown that, in this case, it is difficult the generate
biofilms during CRA, and this test might not be suitable for
identifying the exopolysaccharide layer produced by non-
fermenting Gram-negative bacteria, such as PA.42,43 We
obtained a light pink color mesh, probably due to the
Figure 4. Representative SEM images showing a deterioration of cell
wall of each strain of bacteria, namely, methicillin-resistant Staph-
ylococcus epidermidis (MRSE); Staphylococcus aureus (SA), methicillin-
resistant Staphylococcus aureus (MRSA), and Pseudomonas aeruginosa
(PA). Scale bar = 5 μm (insets = 20 μm); experiments executed at the
corresponding MIC.
Figure 5. Capacity of vescalagin and castalagin (at different
concentrations) to disrupt preformed biofilms from methicillin-
resistant, Staphylococcus epidermidis (MRSE), Staphylococcus aureus
(SA), methicillin-resistant Staphylococcus aureus (MRSA), and
Pseudomonas aeruginosa (PA). The relative formation of biofilm
was quantified by safranin staining. Error bars = SD, * p < 0.05 and
*** p < 0.001 vs “0 mg/mL”; n = 4.
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interference in the cell-to-cell communication process (i.e.,
quorum sensing). Under these conditions, it has been reported
that PA cannot catabolize glucose, and is thus unable to
synthesize the biofilm components.44,45 Our results are also
consistent with the ability of vescalagin/castalagin to efficiently
remodel the adherence proteins (i.e., PIA and PSMs), leading
to bacterial cell death and reduction of the biofilm formation
by PA.
Interestingly, vescalagin/castalagin are more efficient at
inhibiting the growth and killing methicillin-resistant strains.
In fact, Stapleton et al.46 showed that, at low concentrations
(i.e., 0.025 mg/mL), EGCG can reduce the amount of MRSA
by its direct binding to the peptidoglycan layer at the N-
acetylglucosamine and N-acetylmuramic acid residues, but
only if it acts synergistically with the β-lactam oxacillin
(antibiotic of the penicillin class).46 This combinatorial
strategy has been successfully tested not only with EGCG
but also with other polyphenols, e.g. (+)-catechin and
(−)-epicatechin gallate, confirming their ability to enhance
the activity of β-lactam antibiotics. In addition, the MIC
concentration obtained for vescalagin is 4× lower than the one
found for EGCG against the other methicillin-resistant
bacterium, i.e., MRSE.47 As mention before, these strains
express the PBP2a protein that acts as cross-linker of the
peptidoglycan layer. Therefore, it is likely that vescalagin/
castalagin is a strong PBP2a inhibitor, as well as it might also
acts as a modulator of the normal assembly of peptidoglycan,
exopolysaccharides, and proteins, which leads to an inhibition
of biofilm formation and the survival of the methicillin-
resistant strains. In fact, a molecular docking study48
demonstrated that the presence of a carboxylic acid
(COOH), but as well as the two hydroxyls (OH) groups in
the para and ortho positions of an aromatic ring (as in the case
of vescalagin/castalagin) seem to play an important role in the
capacity of phenolic compounds to inhibit the MRSA survival.
We then tested the cytocompatibility of the cork-derived
extracts/polyphenols toward the L929 cell line by the direct
contact method for 24 h. We used concentrations down to the
MIC values (Figure 7 and Figure S15 and S16) envisioning the
exploitation of their antibacterial activity. Vescalagin is
cytocompatible at a concentration of 0.125 mg/mL, which is
its MIC value (Table 1) for the MRSA and MRSE strains
without eliciting cytotoxicity to eukaryotic cells. In the case of
castalagin, it was also found to be cytocompatible at a
concentration of 0.125 mg/mL, which is the MIC value only
for MRSA.
After showing that vescalagin/castalagin are able to inhibit
the proliferation of bacteria, especially the methicillin-resistant
strains, we evaluated if they were also able to elicit the same
activity once loaded into hydrogels typically used in the
development of biomaterials, e.g., alginate (Figure 8). In this
case, we needed to increase the vescalagin/castalagin
concentrations as their spread throughout the 3D structure
of the hydrogel drastically reduces the concentration of the
compounds that are released from the hydrogel and affects the
bacteria. The methicillin-resistant bacteria, i.e., MRSA and
MRSE, presented susceptibility to vescalagin/castalagin already
at a concentration of 2 mg/mL. In the case of SA, we had to
Figure 6. Representative Congo red assay images showing a decrease
in the dark pigmentation consistent with a decrease of amyloid-like
protein presentations for the tested strains of bacteria, namely,
methicillin-resistant Staphylococcus epidermidis (MRSE), Staphylococ-
cus aureus (SA), methicillin-resistant Staphylococcus aureus (MRSA),
and Pseudomonas aeruginosa (PA). Scale bar = 5 mm.
Figure 7. Cytocompatibility of (A) vescalagin and (B) castalagin
toward L929 cells, evaluated by their metabolic activity using
AlamarBlue. MICs are shown for each strain of bacteria, i.e.,
methicillin-resistant Staphylococcus epidermidis (MRSE, 0.125 mg/
mL), Staphylococcus aureus (SA, 0.250 mg/mL), methicillin-resistant
Staphylococcus aureus (MRSA, 0.125 mg/mL), and Pseudomonas
aeruginosa (PA, 1.00 mg/mL). * p < 0.05, ** p < 0.01, *** p < 0.001
(vs 0 mg/mL of vescalagin/castalagin); n = 3.
Figure 8. Ability of vescalagin/castalagin-loaded 3D hydrogels to
reduce bacterial growth. Hydrogels presenting vescalagin and
castalagin (loaded at a concentration of 4 mg/mL) reduce the
bacterial growth for methicillin-resistant Staphylococcus epidermidis
(MRSE), Staphylococcus aureus (SA), methicillin-resistant Staph-
ylococcus aureus (MRSA), but not for Pseudomonas aeruginosa (PA).
Error bars = SD, * p < 0.05 and *** p < 0.001 vs Alg (i.e., 0 mg/mL);
n = 3.
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increase the concentration to 4 mg/mL to observe the same
outcome. For PA, its susceptibility at both concentrations was
weaker, and vescalagin/castalagin were not able to inhibit
bacterial growth in the alginate hydrogels. In general, we
observed the same tendency as the one observed for the direct
inhibition assays, however, at higher concentrations. Despite
this increment in the vescalagin/castalagin concentrations (to
2−4 mg/mL), the loaded hydrogels were not cytotoxic toward
L929 cells (Figure 9).
Overall, we show that vescalagin and castalagin are able to
inhibit bacterial growth for methicillin-resistant Staphylococcus
strains. As a proof of concept, we also demonstrated that these
molecules can be loaded into 3D hydrogels as components that
can be considered in the design of antibacterial biomaterials
that are not cytotoxic to eukaryotic cells.
■ CONCLUSIONS
We investigated the potential of cork-derived extracts/
polyphenols, i.e., CWE, CWE-E, vescalagin, and castalagin, as
antibacterial agents against three Gram-positive bacterial
strains, i.e., MRSE, SA, and MRSA, as well as one Gram-
negative bacterial strain, i.e., PA. Both vescalagin and castalagin
exhibited antioxidant activity, which at the same time might be
related with their capability to act against bacteria machinery in
a process that is still not completely understood.
Vescalagin/castalagin presented antibacterial activity and
were shown to be more effective against methicillin-resistant
bacterial strains. Despite the need for more in-depth studies
regarding their mode of action, vescalagin/castalagin seems to
present a significant impact in the PBP2a-mediated stabiliza-
tion of the peptidoglycan layer of methicillin-resistant bacteria.
They seem to also be able to reduce the formation of β-sheet
supramolecular arrangements necessary to maintain the
bacterial cell wall integrity and biofilm formation. Moreover,
based on results obtained with other polyphenols,46,49 the
antibacterial activity of vescalagin might be enhanced by the
combination of polyphenol and β-lactam antibiotics against
MRSA, an interesting strategy that requires further testing and
validation.
In general, our results can pave the way to the development
of antibacterial vescalagin/castalagin-based methodologies and
their future biomedical application, including the development
of 3D antibacterial hydrogels.
■ EXPERIMENTAL SECTION
Extraction/Enrichment of CWE from Cork Powder, and
Isolation of Vescalagin/Castalagin. The extraction of CWE
followed by the purification of vescalagin and castalagin was
optimized and performed following a procedure previously
published.21 In short, CWE was obtained from cork powder (Amorim
Cork Composites, Portugal) by Soxhlet extraction with water (under
reflux) for 6 h. After cooling, the liquid fraction was filtered and the
solvent was partially removed by vacuum evaporation. The final solid
extracts were recovered by freeze-drying (Figure S1, blue line). CWE-
E was obtained from CWE by an additional step using ethanol: 5 mg/
mL of CWE (in water) was added to 20 mL of ethanol. The
supernatant was collected and the solvent was partially removed by
vacuum evaporation. Afterward, the final solid (CWE-E, Figure S1,
red-dotted line) was recovered by freeze-drying. For the purification
of vescalagin and castalagin, CWE was loaded into a semipreparative
chromatographic column (Waters Atlantis OBD Prep T3, 5 μm 19 ×
250 mm), using the mobile phases A, water:acetic acid 98:2 (v/v),
and B, water:acetonitrile:acetic acid 78:20:2 (v/v/v), under the
following gradient: 100% A (t = 0 min) − 100% A (t = 15 min) −
70% A: 30% B (t = 30 min) − 100% B (t = 35 min) − 100% B (t = 50
min) − 100% A (t = 52 min) − 100% A (t = 57 min). Vescalagin and
castalagin were collected at their respective retention times (Figures
S1 and S3). The flow rate was maintained at 5 mL/min and the
injection volume was 5 mL. The purity of both compounds was
determined by HPLC (KANUER, Germany) using a 4.6 × 250 mm
reverse-phase C18 column (Atlantis, Waters, UK) at flow of 1 mL/
min, using the same mobile phases and gradients as for the
semipreparative HPLC (Figure S3). Mass spectra were acquired on
an electrospray ionization (ESI) mass spectrometer (MS, Water
Micromass Quattro, Waters, USA) under positive-ion mode (Figures
S4 and S5).
Antioxidant Activity. The radical scavenging activity was
measured using 2,2-diphenyl-1-picrylhydrazyl (DPPH), following a
procedure adapted from Santos et al.50 In brief, 20 μL of each extract/
polyphenol was pipetted to a vial with 900 μL of a DPPH solution in
methanol (the initial absorbance was 0.850 ± 0.01). After vigorous
vortexing, the solutions were kept in the dark for 30 min, at 37 °C.
Using a 96-well plate, we measured the absorbance (517 nm) in a
microplate reader (Synergy HT, Bio Tek, USA). The values obtained
were compared with the initial absorbance of the DPPH solution
under methanol (blank). We defined five concentrations (dilutions)
to produce an absorbance decrease of about 50% (EC50). The EC50
was calculated from plotting the scavenging activity against the
extract/polyphenol concentration and represents the concentration of
extract/polyphenol necessary to reduce the initial DPPH concen-
tration by 50%.
Bacterial Strains and Growth Conditions. Staphylococcus
aureus (SA, ATCC 25923), methicillin-resistant Staphylococcus aureus
(MRSA, ATCC 700698), methicillin-resistant Staphylococcus epider-
midis (MRSE, ATCC 35984) and Pseudomonas aeruginosa (PA,
ATCC 27853) were obtained from the American Type Culture
Collection and subcultures were incubated at 37 °C for 18−24 h on
Tryptic soy agar (TSA, ref 610053 and 611001, Liofilchem).
Suspension cultures were prepared by inoculation of single colonies
in 10 mL of Tryptic soy broth (TSB). Afterward, for the preparation
of antibacterial assays, bacteria cells were resuspended in culture
media and the absorbance was adjusted to a turbidity of 0.5
McFarland scale (measured at 640 nm) to an equivalent
concentration of 1−2 × 108 colony forming units (CFUs)/mL.
Disk Diffusion Assay. The antibacterial activity was first
evaluated using the disc diffusion method. The suspension cultures
were prepared on TSB for 24 h at 37 °C under shaking conditions at
120 rpm. Afterwards, the equivalent concentration was adjusted to 1−
2 × 108 colonies forming units (CFUs)/mL, followed by a
homogeneous spreading onto a Muller-Hinton agar plate, (MHA,
70192, Sigma-Aldrich and 611001, Liofilchem), with a sterile swab.
Sterile water was used as negative control, and gentamicin sulfate
(G1914, Sigma-Aldrich) at 50 mg/mL were used as positive control.
Figure 9. Cytocompatibility of 3D hydrogels loaded with vescalagin/
castalagin (at a concentration of 4 mg/mL) toward L929 cells (seeded
on the hydrogels and incubated during 24 h). Metabolic activity
measured using AlamarBlue assay. * p < 0.05 vs Alg; n = 2.
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The disks (9999, Liofilchem) were impregnated with 10 μL of each
cork extracts/polyphenol, and together with the controls were placed
on the inoculated plates and incubated at 37 °C, during 18−24 h.
After the incubation period, the diameter of the clear zone (inhibition
halo diameter) was determined to assess the antibacterial activity of
each extract/polyphenol.
Minimal Inhibitory Concentrations (MICs) and Minimal
Bactericidal Concentration (MBCs). The MIC and the MBC
values were quantified by the microbroth dilution method. The cork
extracts/polyphenols were serially diluted and dispensed into the
wells (50 μL/well) which had been inoculated with 50 μL of the
bacterial suspension at 1−2 × 106 CFUs/mL in Muller-Hinton Broth
(MHB, 70192, Sigma-Aldrich). The well plates were incubated at 37
°C for 24 h under shaking conditions. The MICs of each compound
were considered to be the concentrations at which no turbidity was
observed. Nevertheless, to confirm these results, we dispensed
subcultures of each concentration (10 μL) onto TSA for 24 h. This
assay allowed the confirmation of the MICs values and also to
determine the MBCs of each extract/polyphenol. The experiments
were performed in three independent experiments, each on in
triplicate.
Congo Red Agar Assay. Vescalagin and castalagin were
dispensed into the wells (50 μL/well) of a 96-well plate which were
inoculated with 50 μL of the bacterial suspension at 1−2 × 106
CFUs/mL in MHB. The well plates were incubated at 37 °C for 24 h
under constant agitation. Afterward, each suspension was dispensed
(10 μL) onto TSA plates with 0.08% (w/v) Congo red (C6767,
Sigma-Aldrich) and supplemented with 5% (w/v) sucrose (S0389,
Sigma-Aldrich). The plates were incubated at 37 °C for 24 h. The
colony morphology and color were further analyzed, the staphylococci
biofilm producer strains formed black colonies, whereas the
nonbiofilm producer strains formed red colonies.
Live/Dead Assay and SEM Analysis. Each strain was evaluated
after being in contact with cork extracts/polyphenols for: (i) viability
through Live/Dead assay; and (ii) morphological assessment by SEM
imaging. Briefly, coverslips were placed into the wells with a
suspension of 50 μL of the bacterial suspension at 1−2 × 106
CFUs/mL and 50 μL of extract/polyphenol at their respective MIC
concentrations. After 24 h of incubation, the culture medium was
removed and the samples were fixed with 2.5% (v/v) glutaraldehyde
solution in PBS for 1 h, at 4 °C in the dark. Afterward, the
glutaraldehyde solution was removed, and samples were washed in
PBS solution before dehydration in series of ethanol concentrations
(from 10 to 100% of ethanol). After drying, the samples were
platinum sputtered and visualized by SEM (FIB-SEM, Auriga
Compact, Zeiss, Germany). The other group of samples were
incubated using the Live/Dead BacLight Viability Kit (L23101, Life
Technologies) following the protocol according to the manufacturer’s
instructions. Samples were analyzed by an Inverted Fluorescence
Microscope (Axio Observer, Zeiss, Germany).
Inhibition of Biofilm Formation. Inocule aliquots (300 μL) of
each strain diluted (1:100) in TSB, were dispensed a sterile 96-well
plate, during 24 h for the formation of the slime. The same plates
were again incubated in humidified conditions at 37 °C for 24 h with
shaking at 150 rpm, in the presence and absence of different
concentrations of vescalagin/castalagin. Following incubation, the
liquid was softly removed and each well was washed three times with
sterile phosphate-buffered saline (PBS; pH 7.3) and air-dried.
Adherent bacteria were fixed with 95% ethanol and then stained
with safranine (ScienCell Research Laboratories). The OD at 570 nm
was measured with a Synergy HT microplate reader (Bio-Tek
Instruments).47
Bacterial Growth Inhibition. Disk-forming solutions of alginate
(Pronova UP VLVG, UniversalChemy) were prepared by dissolving
alginate 2% (w/v) in 100 mM CaCl2 (Laborspirit), a alginate cross-
linker solution, containing different concentrations of vescalagin/
castalagin. Each bacteria strain was then added to the 3D hydrogels
disks and the plates were incubated at 37 °C for 24 h. Afterward, 100
μL of each sample was transferred to a 96 well plate and measured at a
wavelength of 600 nm using a Synergy HT microplate reader (Bio-
Tek Instruments).
Cell Line Culture. L929 cells (passages 15−18) were maintained
in DMEM, supplemented with 10% FBS (Alfagene) and 1%
penicillin/streptomycin (Alfagene). Cells were plated at a concen-
tration of 1000 cells/mL, in 96-well plates, incubated at 37 °C under
5% CO2 with the extracts/polyphenols from 2 to 0.125 mg/mL, for
24 h. For the 3D vescalagin/castalagin-loaded hydrogels, cells were
seeded on the gels at a concentration of 50 000 cells/gel using
nonadherent 24-well plate, and incubated at 37 °C under 5% CO2, for
24 h. Cells were then evaluated for their cytocompatibility.
Cytocompatibility. The cytocompatibility of the cork-derived
extracts/polyphenols and the 3D hydrogels loaded with vescalagin/
castalagin was evaluated after 24 h of culture using AlamarBlue
(indicator dye BUF012B, Bio-Rad) according to the manufacturer’s
instructions. The fluorescence intensity of each experimental
condition was measured using an excitation wavelength of 530 nm
and an emission wavelength of 590 nm with a Synergy HT microplate
reader (Bio-Tek Instruments). p-values were calculated using a one-
tailed t test. Results are presented as mean ± SEM of six independent
experiments for each experimental condition.
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Ana C. Araújo − 3B’s Research Group, I3Bs−Research
Institute on Biomaterials, Biodegradables and Biomimetics,
University of Minho, Headquarters of the European Institute
of Excellence on Tissue Engineering and Regenerative
Medicine, 4805-017 Barco, Guimarães, Portugal; ICVS/
3B’s−PT Government Associate Laboratory, Braga/
Guimarães, 4805-017 Barco, Guimarães, Portugal
Rui L. Reis − 3B’s Research Group, I3Bs−Research Institute on
Biomaterials, Biodegradables and Biomimetics, University of
Minho, Headquarters of the European Institute of Excellence
on Tissue Engineering and Regenerative Medicine, 4805-017
Barco, Guimarães, Portugal; ICVS/3B’s−PT Government
ACS Biomaterials Science & Engineering pubs.acs.org/journal/abseba Letter
https://dx.doi.org/10.1021/acsbiomaterials.0c01698
ACS Biomater. Sci. Eng. XXXX, XXX, XXX−XXX
G
Associate Laboratory, Braga/Guimarães, 4805-017 Barco,
Guimarães, Portugal
Complete contact information is available at:
https://pubs.acs.org/10.1021/acsbiomaterials.0c01698
Author Contributions
The manuscript was written through the contributions of all
authors.
Notes
The authors declare no competing financial interest.
■ ACKNOWLEDGMENTS
We acknowledge the financial support from the EC
(FORECAST 668983 and MEPHOS 872648). A.R.A.
acknowledges the “Programa Operacional Regional do
Norte”, “Fundo Social Europeu”, and Norte2020 TERM&SC,
for her PhD grant (NORTE-08-5369-FSE-000044).
■ REFERENCES
(1) Nicoloff, H.; Hjort, K.; Levin, B. R.; Andersson, D. I. The high
prevalence of antibiotic heteroresistance in pathogenic bacteria is
mainly caused by gene amplification. Nature Microbiology 2019, 4 (3),
504−514.
(2) Abraham, W.-R. Controlling Biofilms of Gram-Positive
Pathogenic Bacteria. Curr. Med. Chem. 2006, 13 (13), 1509−1524.
(3) Flemming, H.-C.; Wingender, J. The biofilm matrix. Nat. Rev.
Microbiol. 2010, 8 (9), 623−633.
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